Federated Hermes’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$184K Hold
8,274
﹤0.01% 1507
2025
Q1
$154K Sell
8,274
-36,910
-82% -$686K ﹤0.01% 1533
2024
Q4
$598K Sell
45,184
-272,059
-86% -$3.6M ﹤0.01% 1272
2024
Q3
$10.6M Buy
317,243
+281,186
+780% +$9.42M 0.02% 557
2024
Q2
$904K Buy
36,057
+16
+0% +$401 ﹤0.01% 1141
2024
Q1
$812K Buy
36,041
+14
+0% +$315 ﹤0.01% 1205
2023
Q4
$772K Hold
36,027
﹤0.01% 1225
2023
Q3
$647K Sell
36,027
-17
-0% -$305 ﹤0.01% 1262
2023
Q2
$733K Sell
36,044
-1,303,714
-97% -$26.5M ﹤0.01% 1242
2023
Q1
$29.2M Sell
1,339,758
-1,033,265
-44% -$22.5M 0.07% 302
2022
Q4
$73.5M Buy
2,373,023
+100
+0% +$3.1K 0.2% 109
2022
Q3
$60.5M Buy
2,372,923
+68,826
+3% +$1.76M 0.18% 144
2022
Q2
$46.8M Buy
2,304,097
+700,910
+44% +$14.2M 0.13% 209
2022
Q1
$39.7M Sell
1,603,187
-1,100
-0.1% -$27.2K 0.09% 278
2021
Q4
$55.7M Buy
1,604,287
+662,014
+70% +$23M 0.1% 251
2021
Q3
$25.6M Buy
942,273
+38,866
+4% +$1.05M 0.05% 425
2021
Q2
$23.4M Sell
903,407
-228,861
-20% -$5.93M 0.04% 442
2021
Q1
$24.4M Sell
1,132,268
-187,016
-14% -$4.03M 0.05% 438
2020
Q4
$28.4M Sell
1,319,284
-86,749
-6% -$1.87M 0.06% 375
2020
Q3
$20.7M Sell
1,406,033
-9,277
-0.7% -$137K 0.05% 399
2020
Q2
$31.6M Buy
1,415,310
+141,543
+11% +$3.16M 0.08% 289
2020
Q1
$18M Sell
1,273,767
-1,104,533
-46% -$15.6M 0.05% 354
2019
Q4
$38.6M Buy
2,378,300
+1,054,200
+80% +$17.1M 0.09% 259
2019
Q3
$46.3M Buy
1,324,100
+161,200
+14% +$5.64M 0.11% 203
2019
Q2
$65.6M Buy
1,162,900
+513,280
+79% +$29M 0.16% 145
2019
Q1
$47.5M Buy
649,620
+35,000
+6% +$2.56M 0.12% 198
2018
Q4
$39.2M Buy
614,620
+67,620
+12% +$4.31M 0.11% 207
2018
Q3
$54.6M Buy
547,000
+55,600
+11% +$5.55M 0.13% 182
2018
Q2
$34.9M Buy
491,400
+50,170
+11% +$3.56M 0.1% 168
2018
Q1
$45.9M Buy
441,230
+102
+0% +$10.6K 0.13% 134
2017
Q4
$44.4M Buy
441,128
+274,128
+164% +$27.6M 0.13% 140
2017
Q3
$5.84M Sell
167,000
-33,000
-17% -$1.15M 0.02% 524
2017
Q2
$4.79M Hold
200,000
0.01% 591
2017
Q1
$5.55M Buy
+200,000
New +$5.55M 0.02% 548